World's Best Scientists 2026 revealed!
Claire-Anne Siegrist

Claire-Anne Siegrist

D-Index & Metrics

Immunology

D-Index
90
Citations
26275
World Ranking
1085
National Ranking
27

Medicine

D-Index
90
Citations
26276
World Ranking
12326
National Ranking
167

Claire-Anne Siegrist publication distribution in Immunology in 2026

The chart shows the distribution of publications by all Research.com ranked scientists in the field of Immunology in 2026. The highlighted bar marks where Claire-Anne Siegrist sits on this spectrum.

62–71 publications: 9 scientists 72–81 publications: 23 scientists 82–91 publications: 40 scientists 92–101 publications: 72 scientists 102–111 publications: 86 scientists 112–121 publications: 108 scientists 122–131 publications: 150 scientists 132–141 publications: 160 scientists 142–151 publications: 159 scientists 152–161 publications: 189 scientists 162–171 publications: 166 scientists 172–181 publications: 181 scientists 182–191 publications: 188 scientists 192–201 publications: 187 scientists 202–211 publications: 178 scientists 212–221 publications: 158 scientists 222–231 publications: 168 scientists 232–241 publications: 159 scientists 242–251 publications: 160 scientists 252–261 publications: 148 scientists 262–271 publications: 116 scientists 272–281 publications: 125 scientists 282–291 publications: 115 scientists 292–301 publications: 111 scientists 302–311 publications: 95 scientists 312–321 publications: 97 scientists 322–331 publications: 97 scientists 332–341 publications: 99 scientists 342–351 publications: 96 scientists 352–361 publications: 68 scientists 362–371 publications: 76 scientists 372–381 publications: 71 scientists 382–391 publications: 71 scientists 392–401 publications: 62 scientists 402–411 publications: 54 scientists 412–421 publications: 41 scientists 422–431 publications: 63 scientists 432–441 publications: 53 scientists 442–451 publications: 31 scientists 452–461 publications: 42 scientists 462–471 publications: 40 scientists 472–481 publications: 29 scientists 482–491 publications: 34 scientists 492–501 publications: 30 scientists 502–511 publications: 23 scientists 512–521 publications: 41 scientists 522–531 publications: 29 scientists 532–541 publications: 28 scientists 542–551 publications: 16 scientists 552–561 publications: 18 scientists 562–571 publications: 18 scientists 572–581 publications: 17 scientists 582–591 publications: 17 scientists 592–601 publications: 17 scientists 602–611 publications: 19 scientists 612–621 publications: 13 scientists 622–631 publications: 12 scientists 632–641 publications: 11 scientists 642–651 publications: 16 scientists 652–661 publications: 9 scientists 662–671 publications: 5 scientists 672–681 publications: 13 scientists 682–691 publications: 12 scientists 692–701 publications: 6 scientists 702–711 publications: 6 scientists 712–721 publications: 9 scientists 722–731 publications: 9 scientists 732–741 publications: 6 scientists 742–751 publications: 11 scientists 752–761 publications: 10 scientists 762–771 publications: 7 scientists 772–781 publications: 12 scientists 782–791 publications: 7 scientists 792–801 publications: 5 scientists 802–806 publications: 1 scientists 807+ publications: 100 scientists
62 publications 807+

This scientist: 349 publications — 74th percentile

74% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 807 publications or more.

Claire-Anne Siegrist D-index placement in Immunology in 2026

The chart shows the D-index (discipline H-index) distribution of Immunology scientists ranked by Research.com in 2026. The highlighted bar marks where Claire-Anne Siegrist sits on this spectrum.

40–41 D-Index: 28 scientists 42–43 D-Index: 91 scientists 44–45 D-Index: 157 scientists 46–47 D-Index: 192 scientists 48–49 D-Index: 175 scientists 50–51 D-Index: 188 scientists 52–53 D-Index: 177 scientists 54–55 D-Index: 155 scientists 56–57 D-Index: 194 scientists 58–59 D-Index: 201 scientists 60–61 D-Index: 197 scientists 62–63 D-Index: 201 scientists 64–65 D-Index: 173 scientists 66–67 D-Index: 167 scientists 68–69 D-Index: 172 scientists 70–71 D-Index: 199 scientists 72–73 D-Index: 184 scientists 74–75 D-Index: 133 scientists 76–77 D-Index: 162 scientists 78–79 D-Index: 127 scientists 80–81 D-Index: 121 scientists 82–83 D-Index: 125 scientists 84–85 D-Index: 121 scientists 86–87 D-Index: 102 scientists 88–89 D-Index: 96 scientists 90–91 D-Index: 75 scientists 92–93 D-Index: 72 scientists 94–95 D-Index: 74 scientists 96–97 D-Index: 66 scientists 98–99 D-Index: 68 scientists 100–101 D-Index: 49 scientists 102–103 D-Index: 60 scientists 104–105 D-Index: 54 scientists 106–107 D-Index: 36 scientists 108–109 D-Index: 23 scientists 110–111 D-Index: 52 scientists 112–113 D-Index: 41 scientists 114–115 D-Index: 34 scientists 116–117 D-Index: 25 scientists 118–119 D-Index: 28 scientists 120–121 D-Index: 11 scientists 122–123 D-Index: 20 scientists 124–125 D-Index: 27 scientists 126–127 D-Index: 19 scientists 128–129 D-Index: 20 scientists 130–131 D-Index: 16 scientists 132–133 D-Index: 17 scientists 134–135 D-Index: 14 scientists 136–137 D-Index: 15 scientists 138–139 D-Index: 9 scientists 140–141 D-Index: 11 scientists 142–143 D-Index: 9 scientists 144–145 D-Index: 9 scientists 146–147 D-Index: 7 scientists 148–149 D-Index: 7 scientists 150–151 D-Index: 7 scientists 152–153 D-Index: 5 scientists 154–155 D-Index: 8 scientists 156 D-Index: 6 scientists 157+ D-Index: 96 scientists
40 D-Index 157+

This scientist: 90 D-Index — 79th percentile

79% of scientists in this discipline score the same or lower.

The last bar groups every scientist with 157 D-Index or more.

Overview

Claire-Anne Siegrist is affiliated with the University of Geneva in Switzerland. Their research primarily spans the field of medicine, with a strong focus on infectious diseases. The subfields of study include infectious diseases, immunology, epidemiology, neurology, and genetics.

The scientist's work covers various topics related to viral infections and immune responses, particularly focusing on SARS-CoV-2 and COVID-19 research. Main topics include:

  • SARS-CoV-2 and COVID-19 Research
  • COVID-19 Clinical Research Studies
  • Viral Infections and Outbreaks Research
  • SARS-CoV-2 detection and testing
  • Viral Infections and Vectors
  • Immunotherapy and Immune Responses
  • Respiratory viral infections research

Key publications by Claire-Anne Siegrist include:

  • "Validation of a commercially available SARS-CoV-2 serological immunoassay," 2020, Clinical Microbiology and Infection
  • "Antibody persistence in the first 6 months following SARS-CoV-2 infection among hospital workers: a prospective longitudinal study," 2021, Clinical Microbiology and Infection
  • "Neutralization capacity of antibodies elicited through homologous or heterologous infection or vaccination against SARS-CoV-2 VOCs," 2022, Nature Communications
  • "Robust innate responses to SARS-CoV-2 in children resolve faster than in adults without compromising adaptive immunity," 2021, Cell Reports
  • "Omicron-Specific Cytotoxic T-Cell Responses After a Third Dose of mRNA COVID-19 Vaccine Among Patients With Multiple Sclerosis Treated With Ocrelizumab," 2022, JAMA Neurology

The scientist frequently publishes in venues that include:

  • bioRxiv (Cold Spring Harbor Laboratory)
  • Frontiers in Immunology
  • Clinical Microbiology and Infection
  • European Journal of Clinical Investigation
  • Nature Communications

Collaborations are notable in Claire-Anne Siegrist's research, with frequent coauthors being:

  • Christiane S. Eberhardt
  • Benjamin Meyer
  • Donata Medaglini
  • Laurent Kaiser
  • Angela Huttner

Best Publications

  • Regulation of MHC class II expression by interferon-gamma mediated by the transactivator gene CIITA

    Viktor Steimle;Claire Anne Siegrist;Annick Mottet;Barbara Lisowska-Grospierre

  • Neonatal and early life vaccinology.

    Claire-Anne Siegrist

  • B-cell responses to vaccination at the extremes of age.

    Claire Anne Siegrist;Richard Aspinall

  • CpG DNA can induce strong Th1 humoral and cell-mediated immune responses against hepatitis B surface antigen in young mice.

    Cynthia L. Brazolot Millan;Risini Weeratna;Arthur M. Krieg;Claire-Anne Siegrist

  • Phase 1 Trials of rVSV Ebola Vaccine in Africa and Europe

    Selidji T Agnandji;Angela Huttner;Madeleine E Zinser;Patricia Njuguna

  • Mechanisms by which maternal antibodies influence infant vaccine responses: review of hypotheses and definition of main determinants.

    Claire Anne Siegrist

  • Challenges in infant immunity: implications for responses to infection and vaccines

    Mercy Prabhudas;Becky Adkins;Hayley Gans;Christopher King

  • Effect of prophylactic paracetamol administration at time of vaccination on febrile reactions and antibody responses in children: two open-label, randomised controlled trials

    Roman Prymula;Claire-Anne Siegrist;Roman Chlibek;Helena Zemlickova

  • Revisiting Human IL-12Rβ1 Deficiency: A Survey of 141 Patients From 30 Countries

    Ludovic de Beaucoudrey;Arina Samarina;Arina Samarina;Arina Samarina;Jacinta Bustamante;Jacinta Bustamante;Aurélie Cobat;Aurélie Cobat

  • APRIL is critical for plasmablast survival in the bone marrow and poorly expressed by early-life bone marrow stromal cells

    Elodie Belnoue;Maria Pihlgren;Tracy L. McGaha;Chantal Tougne

  • Neonatal and early life immune responses to various forms of vaccine antigens qualitatively differ from adult responses: predominance of a Th2‐biased pattern which persists after adult boosting

    Christy Barrios;Pierre Brawand;Monika Berney;Christian Brandt

  • Recovery of immune reactivity after T-cell-depleted bone marrow transplantation depends on thymic activity.

    Etienne Roux;Florence Dumont-Girard;Michel Starobinski;Claire-Anne Siegrist

  • TACI, unlike BAFF-R, is solely activated by oligomeric BAFF and APRIL to support survival of activated B cells and plasmablasts

    Claudia Bossen;Teresa G. Cachero;Aubry Tardivel;Karine Ingold

  • Glycoconjugate vaccines and immune interference: A review

    Ron Dagan;Jan Poolman;Claire-Anne Siegrist

  • Low Penetrance, Broad Resistance, and Favorable Outcome of Interleukin 12 Receptor β1 Deficiency Medical and Immunological Implications

    Claire Fieschi;Stéphanie Dupuis;Emilie Catherinot;Jacqueline Feinberg

  • Influence of Mycobacterium bovis bacillus Calmette-Guérin on antibody and cytokine responses to human neonatal vaccination

    Martin O. C. Ota;Johan Vekemans;Susanna E. Schlegel-Haueter;Katherine Fielding

  • The effect of dose on the safety and immunogenicity of the VSV Ebola candidate vaccine: a randomised double-blind, placebo-controlled phase 1/2 trial

    Angela Huttner;Julie-Anne Dayer;Sabine Yerly;Christophe Combescure

  • Importance of background rates of disease in assessment of vaccine safety during mass immunisation with pandemic H1N1 influenza vaccines.

    Steven Black;Juhani Eskola;Claire Anne Siegrist;Neal Halsey

  • Maternal Immunization Earlier in Pregnancy Maximizes Antibody Transfer and Expected Infant Seropositivity Against Pertussis

    Christiane S. Eberhardt;Geraldine Blanchard-Rohner;Barbara Lemaître;Meriem Boukrid

  • Prevention of vertical HIV transmission: additive protective effect of elective Cesarean section and zidovudine prophylaxis. Swiss Neonatal HIV Study Group.

    Christian Kind;Christoph Rudin;Claire-Anne Siegrist;Claire-Anne Wyler

Frequent Co-Authors

Paul-Henri Lambert
Paul-Henri Lambert University of Geneva
Laurent Kaiser
Laurent Kaiser Hôpitaux Universitaires de Genève
Daniel D. Pinschewer
Daniel D. Pinschewer University of Basel
Sabine Yerly
Sabine Yerly University of Geneva
Bernard Mach
Bernard Mach University of Geneva
Arnaud Marchant
Arnaud Marchant Université Libre de Bruxelles
Andrew J. Pollard
Andrew J. Pollard University of Oxford
Melanie J. Newport
Melanie J. Newport Brighton and Sussex Medical School
Isabella Eckerle
Isabella Eckerle University of Geneva
Didier Pittet
Didier Pittet University of Geneva

If you think any of the details on this page are incorrect, let us know.

Report an issue

We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below:

Related Online Degrees & Career Pathways

Studying Immunology in the USA opens doors to various healthcare and research careers, but many students also explore related degrees that complement this field. For those interested in nursing, programs like the lpn schools easy to get into provide accessible entry points into patient care, which can be valuable for gaining practical experience alongside immunology knowledge.

For advanced practice nurses, choosing the easiest fnp program can be a strategic way to balance rigorous study with career advancement. Family Nurse Practitioner (FNP) roles often overlap with immunology in managing chronic diseases and immune-related conditions.

Psychiatric nursing is another growing field linked to immune system research through neuroimmunology. Exploring the top online pmhnp programs can help find quality education coupled with strong clinical opportunities, essential for hands-on experience in mental health care.

Budget-conscious students might prioritize affordability without sacrificing quality by considering the cheapest psychiatric nurse practitioner programs. This ensures access to specialized nursing education that aligns with immunology-related healthcare goals without excessive financial burden.

Best Scientists Citing Claire-Anne Siegrist

Trending Scientists

Recently Published Articles